Recent Articles

Hantavirus explained: What to know after the cruise ship outbreak

Stay strong at any age with 4 basic exercises

Why testosterone levels drop and when to consider treatment

Don't count on daily aspirin to prevent colon cancer

Night owls' habits linked to worse heart health

After ablation, exercise may lower atrial fibrillation recurrence

What can cause an enlarged heart?

Women's unique risks for heart disease

Chronic kidney disease: A hidden threat to your heart

Navigating your online patient portal: Best practices

Adam Kibel, MD, MHCM

Editorial Advisory Board Member, Harvard Health Publishing

Adam Kibel, MD, MHCM, is the chief of urology at Brigham and Women’s Hospital and the Dana-Farber Cancer Institute, and the Elliott Carr Cutler Professor of Surgery at Harvard Medical School. He received his BA and MD from Cornell University in 1987 and 1991 respectively. He then completed his residency at the Harvard Program in Urology (Longwood) in 1997, and a fellowship in urologic oncology at Johns Hopkins in 1999. In 2022, he received a master’s in health care management from Harvard University.

His practice focuses on minimally invasive approaches to urologic cancers. He has over 400 peer-reviewed publications, and has received grant support from multiple agencies, including the National Cancer Institute, the American Urologic Association, the American College of Surgeons, and the Department of Defense. The focus of his research is on identification and treatment of patients with aggressive genitourinary cancers though neoadjuvant therapy, improved imaging, and novel biomarkers.